Solarvest BioEnergy (TSXV:SVS.H) Research & Development: C$0.11 Mil (TTM As of Apr. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Solarvest BioEnergy Research & Development?

Solarvest BioEnergy TSXV:SVS.H Research & Development is C$0.11 Mil as of Apr. 2025.

Research & Development is the aggregate amount of research and development expenses during the year. Solarvest BioEnergy's Research & Development for the three months ended in Apr. 2025 was C$-0.02 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Apr. 2025 was C$0.11 Mil.

Solarvest BioEnergy  (TSXV:SVS.H) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Solarvest BioEnergy Research & Development Related Terms

Solarvest BioEnergy Research & Development Historical Data

* Premium members only.

The historical data trend for Solarvest BioEnergy's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solarvest BioEnergy Research & Development Chart

Solarvest BioEnergy Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 1.02 0.99 0.56 0.08

Solarvest BioEnergy Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.03 0.02 0.09 -0.02

Solarvest BioEnergy Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Apr. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of C$0.11 Mil mean?
Solarvest BioEnergy (TSXV:SVS.H) has a Research & Development of C$0.11 Mil as of Apr. 2025. Research and development expense is the total cost for research and development activities. View historical data on Solarvest BioEnergy and its competitors.
Is Solarvest BioEnergy's Research & Development too high?
Solarvest BioEnergy's current Research & Development is C$0.11 Mil.
How does Solarvest BioEnergy's Research & Development compare to VRTX and REGN?
Solarvest BioEnergy's Research & Development of C$0.11 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Solarvest BioEnergy and its competitors. Solarvest BioEnergy's current Research & Development is C$0.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solarvest BioEnergy stock overvalued right now?
Solarvest BioEnergy (TSXV:SVS.H) has a current Research & Development of C$0.11 Mil. The current Research & Development is C$0.11 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Solarvest BioEnergy (TSXV:SVS.H), the current Research & Development is C$0.11 Mil as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Solarvest BioEnergy Business Description

Address 301 - 1228 Hamilton Street, Vancouver, BC, CAN, V6B 6L2
Solarvest BioEnergy Inc is a Canada based algae biologics company whose production platform provides flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins. The company has also initiated a program for the expression of CBD and THC to be produced.